Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Malignancies × Everolimus × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Neuroendocrine Tumors 3 Tuberous Sclerosis 2 Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Glioma 2 Adenoma, Islet Cell 2 von Hippel-Lindau Disease 1 Unilateral Breast Neoplasms 1 Seizures 1 Recurrence 1 Myelodysplastic Syndromes 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Leukemia, Myeloid, Acute 1 Glioblastoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diffuse Intrinsic Pontine Glioma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoid Tumor 1 Brain Neoplasms 1 Astrocytoma 1 Angiomyolipoma 1 Advanced Lung Neuroendocrine Tumor 1 Advanced Breast Cancer 1

Interventions

Midazolam 2 zanidatamab 1 tislelizumab 1 sitravatinib 1 repaglinide 1 pamiparib 1 lenvatinib 1 drospirenone 1 Temozolomide 1 HMPL-013 1 Ethinyl Estradiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡